Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manan Vora

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Ecancermedicalscience|October 18, 2024
The use of immune checkpoint inhibitors in advanced gastric/gastroesophageal adenocarcinomas - real-world evidence and the use of alternative dosingAditya Dhanawat, Mehak Trikha, Manan Vora, et al.
Cancer|June 21, 2025
Efficacy of losartan plus modified FOLFIRINOX versus modified FOLFIRINOX in advanced pancreatic cancers: A randomized clinical trial (AFPAC Study)Anant Ramaswamy, Prabhat Bhargava, Vikram Gota, et al.
JCO Global Oncology|August 19, 2024
Performance of Low-Dose Immunotherapy and Standard-Dose Immunotherapy in Microsatellite Instability-High Metastatic Colorectal Cancer: Real-World Data (CLouD-High Study)Mehak Trikha, Laboni Sarkar, Aditya Dhanawat, et al.
JCO Global Oncology|December 5, 2024
Gemcitabine Cisplatin and Durvalumab Experience in Advanced Biliary Tract Cancers: A Real-World, Multicentric Data From IndiaVamshi Krishna Muddu, Anjali Shah, Anupa John, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Ecancermedicalscience|October 18, 2024
The use of immune checkpoint inhibitors in advanced gastric/gastroesophageal adenocarcinomas - real-world evidence and the use of alternative dosingAditya Dhanawat, Mehak Trikha, Manan Vora, et al.
Cancer|June 21, 2025
Efficacy of losartan plus modified FOLFIRINOX versus modified FOLFIRINOX in advanced pancreatic cancers: A randomized clinical trial (AFPAC Study)Anant Ramaswamy, Prabhat Bhargava, Vikram Gota, et al.
JCO Global Oncology|August 19, 2024
Performance of Low-Dose Immunotherapy and Standard-Dose Immunotherapy in Microsatellite Instability-High Metastatic Colorectal Cancer: Real-World Data (CLouD-High Study)Mehak Trikha, Laboni Sarkar, Aditya Dhanawat, et al.
JCO Global Oncology|December 5, 2024
Gemcitabine Cisplatin and Durvalumab Experience in Advanced Biliary Tract Cancers: A Real-World, Multicentric Data From IndiaVamshi Krishna Muddu, Anjali Shah, Anupa John, et al.
Pageof 1